Free press releases distribution network?

Agency / Source: Bio-Modeling Systems

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



BMSystems Co-publishes a New Systems Biology Industrial Success Covered by Three Patents - BMSystems co-publishes a new validated systems biology industrial success. These disruptive scientific innovations in the fields of biodefense and biosecurity (protection against multi-resistance bacterial infections) are protected by 3 patents
BMSystems Co-publishes a New Systems Biology Industrial Success Covered by Three Patents

 

PRZOOM - /newswire/ - Paris, Ile-de-France, France, 2010/07/19 - BMSystems co-publishes a new validated systems biology industrial success. These disruptive scientific innovations in the fields of biodefense and biosecurity (protection against multi-resistance bacterial infections) are protected by 3 patents.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BMSystems & Pherecydes-Pharma publish a validated systems biology industrial success, in a reference US biodefense journal. These disruptive scientific innovations in the fields of biodefense and biosecurity (protection against multi-resistance bacterial infections) are protected by 3 patents.

For more information:

• Download the publication: Genetically Engineered Virulent Phage Banks in the Detection and Control of Emergent Pathogenic Bacteria published in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science publication.

Three opportunities to meet our team in a near future:
• Molecular Microbiology Conference organized by CNRS with the support of INRA, INSERM and Institute Pasteur: Dr. François Iris, CSO, is invited to present BMSystems' expertise and achievements in the field of bacteria/phages interactions: Presqu'ile de Giens France: October 11-15, 2010.

• In the United States, to learn more about possible business collaborations with Pherecydes-Pharma, and about BMSystems' developments in the fields of neurodegenerative diseases, psychiatric disorders and multiple sclerosis.

1. French Biotech Tour in Philadelphia: September 14, 2010, where US Pharma/Biotech companies are invited to meet selected French biotech companies focused in CNS, Autoimmunity and Inflammation.

2. BioPharm America partnering in Boston: September 15-17, 2010.

Bio-Modeling Systems (bmsystems.net) is the first and, to date, the only life sciences research-based Company that succeeded to create and to experimentally validate heuristic in-silico models that led to disruptive discoveries, generating patented new knowledge and attractive new businesses launches.

For sustainable business, time to market is a critical issue. Bio-Modeling Systems, a world leading R&D booster for life sciences discoveries, can surely help you save considerable time and resources immediately.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bio-Modeling Systems

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BMSystems Co-publishes a New Systems Biology Industrial Success Covered by Three Patents

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Manuel Gea - BMSystems.net 
+33(0)6 83 06 12 72 manuel.gea[.]bmsystems.net
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Modeling Systems securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Bio-Modeling Systems / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  RightITnow Ltd

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today